These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2388887)

  • 1. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG; Nikitina OI
    Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI; Gergert VIa; Khomenko IS
    Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
    Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of pulmonary tuberculosis].
    Khudzik LB; Salina TIu; Parolina LE
    Probl Tuberk; 1998; (6):23-6. PubMed ID: 10067345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of functional activity of lymphocytes in patients with tuberculosis and in patients of group IIIA of clinic registries by electrophoretic mobility].
    Morozova TI; Khudzik LB; Tikhomirova LA
    Probl Tuberk; 1994; (2):40-2. PubMed ID: 8036219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
    Bulava GV; Nikulina VP
    Khirurgiia (Mosk); 1996; (2):104-7. PubMed ID: 8754918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
    Ivanova LA
    Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the functional activity of blood lymphocytes in patients with destructive pulmonary tuberculosis during the treatment].
    Kibrik BS; Krylova GO; Kolesnikov VA
    Probl Tuberk; 1991; (10):63-6. PubMed ID: 1788236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
    Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.